Hims & Hers Health, Inc. (HIMS) vs Liquidia Corporation (LQDA)
Hims & Hers Health, Inc. and Liquidia Corporation are both Drug Manufacturers Specialty & Generic companies. Hims & Hers Health, Inc. and Liquidia Corporation are of similar size ($6.9B and $6.4B). Hims & Hers Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Liquidia Corporation trades at 43.6×. Liquidia Corporation grew revenue faster over the last twelve months: 2,233.7% against 28.0%. Liquidia Corporation has the higher net margin (30.7% vs −5.51%) and the higher return on invested capital (121.1% vs −11.4%). Across the 19 metrics below, Liquidia Corporation leads on 16 and Hims & Hers Health, Inc. on 3.
Valuation
Profitability
| Metric | HIMS | LQDA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 68.43% | 92.54% | 53.94% |
| Operating margin | (5.99%) | 37.39% | 0.00% |
| Net margin | (5.51%) | 30.74% | 0.00% |
| Free cash flow margin | 3.22% | 33.42% | 0.00% |
| Return on equity | (32.03%) | 131.82% | (0.40%) |
| Return on assets | (5.16%) | 35.57% | (3.32%) |
| Return on invested capital | (11.38%) | 121.05% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack